Net Cash Provided by (Used in) Operating Activities |
266M |
USD |
+19.4% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
1.2B |
USD |
-57.9% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-1.87B |
USD |
-196% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
200M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
170M |
shares |
+0.34% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-404M |
USD |
-116% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
4.37B |
USD |
-31.6% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
600M |
USD |
+164% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
604M |
USD |
-1.18% |
Q4 2023 |
FY 2023 |
Operating Lease, Liability |
89.6M |
USD |
-18.8% |
Q2 2024 |
Q2 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
1.23B |
USD |
+13.1% |
Q2 2024 |
Q2 2024 |
Deferred Income Tax Expense (Benefit) |
-6.91M |
USD |
-1234% |
Q1 2024 |
Q1 2024 |
Unrecognized Tax Benefits |
1.19M |
USD |
+150% |
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
2.01B |
USD |
+2.44% |
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
51M |
USD |
+56.6% |
Q1 2024 |
Q1 2024 |
Interest Expense |
1.75B |
USD |
+116% |
Q2 2024 |
Q2 2024 |